Analytical Data
-
Gene name
C1orf106
- Application
-
Alternative Names
C1orf106; CA106_HUMAN; Chromosome 1 open reading frame 106 ; FLJ10901; Uncharacterized protein C1orf106
-
Species
Human
-
Source
Yeast
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q3KP66
-
Expression Region
1-578aa
-
Molecular Weight
65.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C1orf106, also known as Chromosome 1 Open Reading Frame 106, has emerged as a protein of interest due to its potential roles in various biological processes and diseases. Initially identified through genomic studies, C1orf106's precise function remains largely uncharacterized; however, it is speculated to play a role in cellular mechanisms such as apoptosis, signal transduction, and immune responses. Recent research has highlighted its involvement in certain cancers and neurodegenerative disorders, suggesting that it may serve as a potential biomarker or therapeutic target. The production of recombinant C1orf106 protein allows for detailed investigation of its structural and functional properties, enabling researchers to elucidate its biological roles and interactions within cellular pathways. Furthermore, recombinant proteins facilitate the study of post-translational modifications and interactions with other biomolecules, thereby enhancing our understanding of how C1orf106 may influence cellular homeostasis. As the demand for novel therapeutic strategies increases, understanding the role of C1orf106 in health and disease could pave the way for innovative interventions and improved outcomes in various pathological conditions. Consequently, ongoing studies focusing on the recombinant production and functional analysis of C1orf106 are critical for deciphering its contributions to human health and developing targeted therapies.
